Quest Diagnostics Incorporated
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Quest Diagnostics Incorporated's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $35 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 92% of Healthcare companies in United States.
- Tangible Net Worth Ratio: Goodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative. Less tangible than 87% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 23% of its market value (net debt). Lower than 86% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$165Over the last 3 years, every $100 of reported profit came with $165 of operating cash.
Higher than 61% of Healthcare companies in United States.
Self-Funding Ratio
3.3×Over the last 3 years its own operating cash covered its investment spending (capex) 3.3 times.
Higher than 80% of Healthcare companies in United States.
Cash Locked Ratio
$10For every $100 of sales, $10 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $10 tied up three years earlier.
Less money tied up than 80% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
2/3 · 2/3Sales grew in 2 of the last 3 years; profit grew in 2 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
$4Sales grew 12% in 3 years; of every extra $100 of sales, $4 became extra profit.
Lower than 63% of Healthcare companies in United States.
Asset Productivity Ratio
+12% / +26%In 3 years sales changed by +12% while total assets changed by +26%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
2.7×Debt due within a year is covered 2.7 times by its yearly operating cash.
Higher than 76% of Healthcare companies in United States.
Cash Cushion Ratio
−23%Debt, after subtracting cash, equals 23% of its market value (net debt).
Lower than 86% of Healthcare companies in United States.
Tangible Assets Ratio
35%Of every $100 the company owns, $35 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 92% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 87% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Quest Diagnostics Incorporated owes $0.53 for every $1 it owns. Net profit rose 14% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
25.8Investors pay $25.8 for every $1 of Quest Diagnostics Incorporated's yearly profit, lower than 52% of Healthcare companies in United States.
P/B ratio
3.57The share price is 3.57 times Quest Diagnostics Incorporated's book value per share, higher than 61% of Healthcare companies in United States.
Market cap
$26.9 BThe total market value of all of Quest Diagnostics Incorporated's shares at today's price (share price × number of shares), larger than 94% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$7.5 BWhat Quest Diagnostics Incorporated would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$68.10Net worth divided by the number of shares. The share price of $243.28 is 3.6 times this, which is the P/B above.
Return on equity (ROE)
14.6%Quest Diagnostics Incorporated earned 14.6% on its shareholders' money over the last year, higher than 87% of Healthcare companies in United States.
Owes vs Owns
0.53×Quest Diagnostics Incorporated owes $0.53 for every $1 it owns (moderate), higher than 59% of Healthcare companies in United States.
Dividend yield
1.44%Quest Diagnostics Incorporated pays 1.44% of its share price as dividends a year, higher than 61% of dividend-paying Healthcare companies in United States.
Revenue growth
+12%Revenue rose 12% in the year to Dec 2025, and grew 4% a year on average over 3 years.
Profit growth
+14%Net profit rose 14% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Profit margin
9.0%Quest Diagnostics Incorporated keeps $9 of every $100 of revenue as net profit.
Cash quality
1.9×Cash from Quest Diagnostics Incorporated's business was 1.9× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
5.6×Quest Diagnostics Incorporated's operating profit covered its interest costs 5.6 times in the year to Dec 2025.
Cash vs debt
Net debtQuest Diagnostics Incorporated had $6.2 B more debt than cash (net debt) at Dec 2025.
Questions
What is Quest Diagnostics Incorporated's P/E ratio?
Investors pay $25.8 for every $1 of Quest Diagnostics Incorporated's yearly profit, lower than 52% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Quest Diagnostics Incorporated: $26.9 B ÷ $7.5 B (30 Jun 2026) = 3.6.
What is Quest Diagnostics Incorporated's return on equity?
Quest Diagnostics Incorporated earned 14.6% on its shareholders' money over the last year, higher than 87% of Healthcare companies in United States.
How much does Quest Diagnostics Incorporated owe compared with what it owns?
Quest Diagnostics Incorporated owes $0.53 for every $1 it owns (moderate), higher than 59% of Healthcare companies in United States.
Does Quest Diagnostics Incorporated pay a dividend?
Yes. Quest Diagnostics Incorporated pays 1.44% of its share price as dividends a year, higher than 61% of dividend-paying Healthcare companies in United States.
Is Quest Diagnostics Incorporated's revenue growing?
Revenue rose 12% in the year to Dec 2025, and grew 4% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.